Kiniksa Pharmaceuticals International Plc (KNSA)
40.84
-0.30
(-0.72%)
USD |
NASDAQ |
Dec 10, 11:22
Kiniksa Pharmaceuticals International EPS Diluted (Quarterly): 0.2303 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| NovoCure Ltd. | -0.333 |
| LivaNova Plc | 0.4856 |
| ADMA Biologics, Inc. | 0.1489 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 18.44M |
| Revenue (Quarterly) | 180.86M |
| Total Expenses (Quarterly) | 162.42M |
| Enterprise Value | 2.776B |
| Gross Profit Margin (Quarterly) | 53.78% |
| Profit Margin (Quarterly) | 10.19% |
| Earnings Yield | 1.10% |
| Operating Earnings Yield | 1.22% |
| Normalized Earnings Yield | 1.098 |